Patents Assigned to Region Midjylland
  • Publication number: 20120252041
    Abstract: The present invention relates to the use of soluble CD163 as a prognostic marker for the assessment of the risk for contracting a disorder, in particular for contracting diabetes and/or a liver disorder. The invention also relates to the use of CD163 as a prognostic marker for assessing lifetime expectancy.
    Type: Application
    Filed: October 12, 2010
    Publication date: October 4, 2012
    Applicants: Region Midjylland, Aarhus Universitet
    Inventors: Søren Moestrup, Ruth Frikke-Schmidt, Anne Tybjaerg-Hansen, Holger J. Møller